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journal homepage: www.e lsev ier .com/ locate / j j ccneointima: Are they ‘‘true colors’’ shining through?Intravascular ultrasound (IVUS) has been developed as a novel
gray scale imaging of the coronary vessel wall in vivo. IVUS-based
cross-sectional imaging provides additional information, such as
vessel, lumen, and plaque area and thus helps the undertaking of
percutaneous coronary interventionmore effectively and safely. In
addition to the quantitative assessment, visual interpretations of
the gray scale IVUS image may help in assessing plaque as well as
neointimal characteristics. Despite the fact that we can assess
plaque vulnerability as well as risk for slow ﬂow/no reﬂow during
PCI [1,2], gray scale IVUS-derived tissue qualitative assessment
may not be enough because of its subjective and less quantitative
nature.
Three different IVUS-based tissue characterization algorithms
based on radio frequency signal processing have been developed to
provide more objective and quantitative information of the
coronary plaque in vivo [3–5]. One of the tissue characterizations
is virtual histology intravascular ultrasound (VH-IVUS) [3]. VH-
IVUS-based tissue characterization has been reported as useful to
predict coronary microembolization during percutaneous coro-
nary intervention [3] and future coronary events [6]. The second
tissue characterization technique is an integrated backscatter (IB)-
IVUS [5,7–9]. Similar to the VH-IVUS, IB-IVUS may be useful to
detect unstable or vulnerable plaque [5] and future coronary
events [8]. Although these tissue characterization systems have
been validated to assess coronary plaque by comparing with
histology [7], IB-IVUS may have some role in the assessment of
intrastent neointimal tissue characterization [10]. In fact, IVUS has
been used to quantitate in-stent neointimal hyperplasia [11].
Therefore, use of tissue characterization may have an additional
role in volumetric neointimal analysis using gray scale IVUS alone.
In this issue of the journal, Araki and co-workers [12], by using
another IVUS-based tissue characterization system [12], iMap
[9,13], reported that in-stent neointimal tissue components may
be different between early and late drug-eluting stent restenosis.
The iMap has been developed as the third IVUS-based tissue
characterization system [9,13]. The iMap classiﬁes tissue compo-
nents into four categories: ﬁbrotic, lipidic, necrotic, and calciﬁed
[13]. Although iMap has not been developed to assess in-stent
neointima but to assess atherosclerotic coronary plaque, it may be
possible to clarify the differences in the in-stent neointimal tissue
components. In fact, in-stent neointimal tissue componentsDOI of original article: http://dx.doi.org/10.1016/j.jjcc.2014.03.001
http://dx.doi.org/10.1016/j.jjcc.2014.05.002
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late (>1 year) in-stent stenoses. This is in agreement with a
previous study using optical coherence tomography showing that
late in-stent restenosis after drug-eluting stent implantation may
have neoatherosclerosis [14]. Because IVUS has an advantage over
optical coherence tomography with respect to the assessment of
entire vessel structure [15], iMap-based tissue characterization
may have some clinical implications.
Although the results of this manuscript are interesting, several
limitations should be addressed. First, iMap-derived tissue
characterization is not compatible with other tissue characteriza-
tion techniques because of differences in the signal processing
algorithm [9]. Therefore, these results should be carefully
interpreted. Similarly, because iMap does not have histological
validation for in-stent neointimal tissue, the iMap ﬁndings need to
be conﬁrmed by histological examination. Finally, the impact of
iMap ﬁndings of in-stent neointimal tissue on future events or risk
of slow ﬂow/no reﬂow during percutaneous coronary intervention
is uncertain. Color-coded IVUS images are beautiful as if they are
providing ‘‘true colors’’ of the in-stent neointimal tissue char-
acteristics. However, until the above issues are addressed, these
colors should be interpreted as virtual rather than true colors.
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